Ingrédients et solutions pour l’industrie alimentaire

Microbiome

Micro-organismes et principes actifs pour la santé humaine

Agro-vet

Ferments lactiques pour le secteur agro-vétérinaire

SACCO SYSTEM at Vitafoods, May 9-11, in Geneva at Palexpo booth G260

03/05/2023

SACCO SYSTEM at Vitafoods, May 9-11, in Geneva at Palexpo, Route François-Peyrot 30, 1218 Le Grand-Saconnex, Switzerland.

We look forward to meeting you for three days of inspiration and networking within the microbiome industry.

Visit our booth G260 to connect with our team of experts and hear more about Sacco System’s CultureScience™ and CultureSelect™ portfolio or discover more about our custom fermentation capabilities for probiotics, postbiotcs, next-generation bacteria and live biotherapeutics.

Our services are MADE FOR YOU™

We understand that you might look for a tailor-made solution for the microbiome space, at Sacco System we aim to be your all-in-one partner, we take care of the manufacturing and science, and you can stay focused on your business.

Probiotics, postbiotics, next-generation bacteria and live biotherapeutics, from development to production, we have you covered!


Gut microbiota modulations by probiotics improve inflammaging and metabolic disorders
Wednesday, May 10, 2023 at 3:00 p.m. at the Probiotics Theatre
Speaker: Valentina Taverniti, PhD, Health and Nutrition R&D Scientist at Sacco System

There is increasing evidence of the health benefits of probiotic formulations, both single-strain and multistrain formulations. It is well known that the benefits of orally administered probiotics can extend beyond the gut. Among other mechanisms through which this can take place, the modulation of the gut microbiota composition by probiotics is an important one, as it can result in different metabolites being produced, and thus regulate specific host cell pathways and responses. In this context, we present a clinical study focused on the use of Lactiplantibacillus plantarum IMC 510® on weight management and metabolic improvement of the study participants, and a clinical study of a well-characterized mixture of L. rhamnosus IMC 501® and L. paracasei IMC 502®, named SYNBIO®, that improved inflammaging and the nutritional status in elderly volunteers.

Latest News

19 mars 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 janvier 2026
SYNBIO®: Sacco System’s probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

20 novembre 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 février 2025
L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 janvier 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 novembre 2024
News, News
Notre rapport de développement durable 2023 est on-line!

Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir…

16 avril 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the

26 mars 2024
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco

18 mars 2024
List Biotherapeutics and Sacco System Announce Lead Share Agreement

Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce

26 février 2024
News, News
CSL FRANCE devient SACCO SYSTEM FRANCE

Sacco System est le pôle biotechnologique international dédié à l’industrie alimentaire, nutraceutique pharmaceutique, basé sur la tradition…

21 février 2024
Sacco System Supports Action4Diabetes’ mission

We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,

19 février 2024
Exploring a Future Without Stereotypes: SACCO SYSTEM at Liceo Scientifico Cavalleri for DYT

This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration